Obserwuj
alastair gray
alastair gray
Emeritus Professor of Health Economics, University of Oxford
Zweryfikowany adres z dph.ox.ac.uk
Tytuł
Cytowane przez
Cytowane przez
Rok
Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials
CT Trialists
The Lancet 376 (9753), 1670-1681, 2010
4230*2010
The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials.
B Mihaylova, J Emberson, L Blackwell, A Keech, J Simes, EH Barnes, ...
Lancet (London, England) 380 (9841), 581-590, 2012
22572012
The economic burden of back pain in the UK
N Maniadakis, A Gray
Pain 84 (1), 95-103, 2000
21512000
Economic burden of cancer across the European Union: a population-based cost analysis
R Luengo-Fernandez, J Leal, A Gray, R Sullivan
The lancet oncology 14 (12), 1165-1174, 2013
11942013
Economic burden of cardiovascular diseases in the enlarged European Union
J Leal, R Luengo-Fernández, A Gray, S Petersen, M Rayner
European heart journal 27 (13), 1610-1619, 2006
10842006
European cardiovascular disease statistics 2012
M Nichols, N Townsend, R Luengo-Fernandez, J Leal, A Gray, ...
9762012
Radiotherapy plus cisplatin or cetuximab in low-risk human papillomavirus-positive oropharyngeal cancer (De-ESCALaTE HPV): an open-label randomised controlled phase 3 trial
H Mehanna, M Robinson, A Hartley, A Kong, B Foran, T Fulton-Lieuw, ...
The Lancet 393 (10166), 51-60, 2019
8922019
European cardiovascular disease statistics
S Allender, P Scarborough, V Peto, M Rayner, J Leal, ...
European Heart Network 3, 11-35, 2008
8442008
Applied methods of cost-effectiveness analysis in healthcare
AM Gray, PM Clarke, JL Wolstenholme, S Wordsworth
OUP Oxford, 2010
8172010
A model to estimate the lifetime health outcomes of patients with type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS) Outcomes Model (UKPDS no. 68)
PM Clarke, AM Gray, A Briggs, AJ Farmer, P Fenn, RJ Stevens, ...
Diabetologia 47, 1747-1759, 2004
7662004
Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
RECOVERY Collaborative Group, PW Horby, M Mafham, L Peto, ...
Medrxiv, 2021.06. 15.21258542, 2021
631*2021
Knee replacement
AJ Price, A Alvand, A Troelsen, JN Katz, G Hooper, A Gray, A Carr, ...
The Lancet 392 (10158), 1672-1682, 2018
6102018
Estimating utility values for health states of type 2 diabetic patients using the EQ-5D (UKPDS 62)
P Clarke, A Gray, R Holman
Medical Decision Making 22 (4), 340-349, 2002
6022002
European cardiovascular disease statistics
J Leal, R Luengo-Fernandez, A Gray
British Heart Foundation, 2000
5142000
Effect of 3 to 5 years of scheduled CEA and CT follow-up to detect recurrence of colorectal cancer: the FACS randomized clinical trial
JN Primrose, R Perera, A Gray, P Rose, A Fuller, A Corkhill, S George, ...
Jama 311 (3), 263-270, 2014
5082014
Cost effectiveness of an intensive blood glucose control policy in patients with type 2 diabetes: economic analysis alongside randomised controlled trial (UKPDS 41)
A Gray, M Raikou, A McGuire, P Fenn, R Stevens, C Cull, I Stratton, ...
Bmj 320 (7246), 1373-1378, 2000
4812000
Handling uncertainty when performing economic evaluation of healthcare interventions.
AH Briggs, AM Gray
Health technology assessment (Winchester, England) 3 (2), 1-134, 1999
4641999
Arthroscopic subacromial decompression for subacromial shoulder pain (CSAW): a multicentre, pragmatic, parallel group, placebo-controlled, three-group, randomised surgical trial
DJ Beard, JL Rees, JA Cook, I Rombach, C Cooper, N Merritt, BA Shirkey, ...
The Lancet 391 (10118), 329-338, 2018
4632018
UKPDS outcomes model 2: a new version of a model to simulate lifetime health outcomes of patients with type 2 diabetes mellitus using data from the 30 year United Kingdom …
AJ Hayes, J Leal, AM Gray, RR Holman, PM Clarke
Diabetologia 56, 1925-1933, 2013
4542013
A longitudinal study of the effects of age and time to death on hospital costs
M Seshamani, AM Gray
Journal of health economics 23 (2), 217-235, 2004
4332004
Nie można teraz wykonać tej operacji. Spróbuj ponownie później.
Prace 1–20